Background and Purpose: Viridans streptococci (VS) are part of the normal flora of humans,
but are fast emerging as pathogens causing bacteremia in neutropenic patients. The clinical …

The authors discuss the morbidity associated with viridans streptococcus bacteremia, and its
implications on the choice of antibiotics used as prophylaxis and treatment. They …

Viridans group streptococci bloodstream infections (VGS BSI) remain a significant cause of
mortality and morbidity in patients with severe neutropenia. The goal of our study was to …

Background Infections remain an important cause of morbidity and mortality in children with
acute myeloid leukemia (AML), and particularly viridans group streptococci (VGS) sepsis …

Viridans group Streptococcus (VGS) is a leading cause of bacteremia in pediatric oncology
patients, primarily in children with acute myeloid leukemia or after hematopoietic stem cell …

Infection with viridans group streptococci (VGS) causes morbidity and mortality in children
with cancer. Incidence of these infections has increased over time. Neutropenic patients with …

Abstract Viridans Group Streptococci (VGS) are associated with high mortality rates in febrile
neutropenia; yet there are no recent European pediatric studies to inform antimicrobial …

Our aim was to determine the significance of species identification and penicillin
susceptibility of viridans streptococci in children with malignancies. Streptococcus mitis …

Objectives: We studied the species distribution and antimicrobial susceptibility of viridans
streptococci (VS) isolates causing nosocomial bloodstream infections (BSIs) in Finnish …

Background: Viridans group streptococci (VGS) cause significant morbidity in children
treated for acute myeloid leukemia (AML). Our goals were to determine the occurrence and …